Quantcast

Latest Diagnostic tests Stories

2011-02-03 00:00:43

BioDot, the leading supplier of system tools for the research, development, and commercialization of diagnostic tests is relocating to a larger facility in Irvine, CA. The new facility has approximate 24,000 sq. ft. Irvine, CA (PRWEB) February 2, 2011 The new facility has approximate 24,000 sq. ft. In addition, the new facility will also allow us to have a larger application lab to continue to work with our customers as well as host our ongoing "hands on" workshops in house. On February 4,...

2011-01-19 15:05:00

- Agreement on a shareholder rights plan - QUEBEC CITY, Jan. 19 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering lab services, today reported financial and operation results for the fourth quarter 2010 and fiscal year ended October 31, 2010. The Company announced a net loss of $1,141,903 or $0.03 per share for the fourth quarter ending October 31, 2010, and a net loss of $8,817,417 or $0.21...

2010-12-10 17:30:00

SAN DIEGO, Dec. 10, 2010 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today new findings from a clinical study evaluating the company's Breast Cancer Index( )(BCI) molecular oncology test. Data from the study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). The company also announced that the Breast Cancer Index is now available to...

2010-11-11 14:39:28

Discovery may guide treatment for acute myeloid leukemia Decoding the DNA of a woman who died of acute myeloid leukemia (AML) has led researchers at Washington University School of Medicine in St. Louis to a gene that they found to be commonly altered in many patients who died quickly of the disease. The findings, if confirmed in larger studies, suggest that a diagnostic test for mutations in the gene could identify AML patients who need more aggressive treatment right from the start. The new...

2010-09-21 22:15:48

Press release from PLoS Medicine Community Health Workers can safely and effectively provide integrated management of pneumonia and malaria to communities by dispensing amoxicillin to children with non-severe pneumonia and artemether-lumefantrine to children with malaria (after using rapid diagnostic tests). Furthermore, these activities result in a significant increase in the proportion of appropriately-timed antibiotic treatment for non-severe pneumonia and in a significant decrease in...

2010-09-13 15:05:00

QUEBEC CITY, Sept. 13 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the third quarter 2010 ended July 31, 2010. The Company announced a net loss of $1,650,593 or $0.04 per share for the third quarter 2010. These results reflect activities undertaken during this quarter and on-going commitment to develop high-value diagnostic...

56976a40022cb40e476fa3e8274ecaf71
2010-08-19 10:25:00

Patients suffering from active tuberculosis (TB) have a specific pattern of genes in their blood, according to a new study from scientists which could lead to better diagnostic tests and improved treatment methods for those suffering from the often deadly infectious disease.The so-called "genetic signature"--discovered by a team of researchers led by Anne O'Garra of the Medical Research Council (MRC)--is present in as many as 10% of the approximately 2 billion people worldwide who are...

2010-08-18 08:51:00

MISSISSAUGA, Ontario, Aug. 18 /PRNewswire-FirstCall/ -- Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Care(TM) Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, took part in an interview on Canada's Business News Network (BNN) on Monday, August 16th to discuss the market potential and technical advantages of the Company's paramagnetic beads and QL Care Analyzer(TM). On the...

2010-06-09 15:31:00

QUEBEC CITY, June 9 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter 2010 ended April 30, 2010. The Company announced a net loss of $2,204,832 or $0.05 per share per share for the second quarter 2010. These results reflect activities undertaken during this quarter and on-going commitment to develop high-value...

2010-06-06 07:00:00

SAN DIEGO, June 6 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago. On June 5(th), scientists from...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.